The Pulmonary Hypertension Association (PHA) and Washington University School of Medicine, Continuing Medical Education are pleased to announce our latest continuing medical education (CME) initiative — live medical education on demand. This program allows you to design a CME meeting that meets your medical community’s educational needs concerning pulmonary hypertension (PH).
Steps for Requesting a Program
For Medical Professionals Only
Download Form for Fax or Mail (PDF)
Attend a Program
Interested in attending an event? Click below to view the schedule and register for a program.
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.
This CME program is designed to improve competence, performance, and patient care practices by instructing clinicians in the highest quality of care for patients with PAH. At the conclusion of the program, participants should be able to:
- Accurately diagnose patients through comprehensive screening and early recognition of symptoms
- Evaluate the patient’s condition and prescribe long-term optimal management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
Accreditation and Credit Designation
This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of off-label/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.
These programs, administered within ACCME guidelines and according to the specifications outlined, are offered at no cost to pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PH.
|Actelion Pharmaceuticals US, Inc.
||Gilead Sciences, Inc.
United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through educational grants from our supporters.